Advertisement

Index by author

May 01, 2001; Volume 297,Issue 2

  1. Abebe, Daniel T.

    1. Prevention of Fetal Demise and Growth Restriction in a Mouse Model of Fetal Alcohol Syndrome
      Catherine Y. Spong, Daniel T. Abebe, Illana Gozes, Douglas E. Brenneman and Joanna M. Hill
      Journal of Pharmacology and Experimental Therapeutics May 2001, 297 (2) 774-779;

  2. Akahane, Masuo

    1. Pharmacological Characterization of KUR-1246, a Selective Uterine Relaxant
      Mamoru Kobayashi, Keiko Takeda, Satoshi Murata, Masami Kojima, Masuo Akahane, Yoshihito Inoue, Kenji Kitamura and Tatsuhiko Kawarabayashi
      Journal of Pharmacology and Experimental Therapeutics May 2001, 297 (2) 666-671;

  3. Alden, Kris J.

    1. Differential Effect of Gabapentin on Neuronal and Muscle Calcium Currents
      Kris J. Alden and Jesús Garcı́a
      Journal of Pharmacology and Experimental Therapeutics May 2001, 297 (2) 727-735;

  4. Ananthan, Subramaniam

    1. In Vivo Pharmacological Characterization of SoRI 9409, a Nonpeptidic Opioid μ-Agonist/δ-Antagonist That Produces Limited Antinociceptive Tolerance and Attenuates Morphine Physical Dependence
      Jennifer L. Wells, Jeffrey L. Bartlett, Subramaniam Ananthan and Edward J. Bilsky
      Journal of Pharmacology and Experimental Therapeutics May 2001, 297 (2) 597-605;

  5. Aoki, Ikuo

    1. Pharmacological Properties of (2R)-N-[1-(6-Aminopyridin-2-ylmethyl)piperidin-4-yl]-2-[(1R)-3,3-difluorocyclopentyl]-2- hydroxy-2-phenylacetamide: A Novel Muscarinic Antagonist with M2-Sparing Antagonistic Activity
      Hiroyasu Hirose, Ikuo Aoki, Toshifumi Kimura, Toru Fujikawa, Tomoshige Numazawa, Kaori Sasaki, Akio Sato, Takuro Hasegawa, Masaru Nishikibe, Morihiro Mitsuya, Norikazu Ohtake, Toshiaki Mase and Kazuhito Noguchi
      Journal of Pharmacology and Experimental Therapeutics May 2001, 297 (2) 790-797;

  6. Appel, Sarah B.

    1. Electrophysiological Effects of Cocaethylene, Cocaine, and Ethanol on Dopaminergic Neurons of the Ventral Tegmental Area
      E. Bradshaw Bunney, Sarah B. Appel and Mark S. Brodie
      Journal of Pharmacology and Experimental Therapeutics May 2001, 297 (2) 696-703;

  7. Arima, Hidetoshi

    1. Contribution of P-glycoprotein to the Enhancing Effects of Dimethyl-β-cyclodextrin on Oral Bioavailability of Tacrolimus
      Hidetoshi Arima, Kiyokazu Yunomae, Fumitoshi Hirayama and Kaneto Uekama
      Journal of Pharmacology and Experimental Therapeutics May 2001, 297 (2) 547-555;

  8. Azizi, Michel

    1. RXP 407, a Selective Inhibitor of the N-Domain of Angiotensin I-Converting Enzyme, Blocks in Vivo the Degradation of Hemoregulatory Peptide Acetyl-Ser-Asp-Lys-Pro with No Effect on Angiotensin I Hydrolysis
      Christophe Junot, Marie-Francoise Gonzales, Eric Ezan, Joel Cotton, Gilles Vazeux, Annie Michaud, Michel Azizi, Stamatia Vassiliou, Athanasios Yiotakis, Pierre Corvol and Vincent Dive
      Journal of Pharmacology and Experimental Therapeutics May 2001, 297 (2) 606-611;

  9. Bai, Xu

    1. Characterization of the Caspase Inhibitor IDN-1965 in a Model of Apoptosis-Associated Liver Injury
      Niel C. Hoglen, Brad P. Hirakawa, Craig D. Fisher, Suzanne Weeks, Anu Srinivasan, Angela M. Wong, Karen L. Valentino, Kevin J. Tomaselli, Xu Bai, Don S. Karanewsky and Patricia C. Contreras
      Journal of Pharmacology and Experimental Therapeutics May 2001, 297 (2) 811-818;

  10. Baldessarini, Ross J.

    1. Long-Term Effects of Olanzapine, Risperidone, and Quetiapine on Dopamine Receptor Types in Regions of Rat Brain: Implications for Antipsychotic Drug Treatment
      Frank I. Tarazi, Kehong Zhang and Ross J. Baldessarini
      Journal of Pharmacology and Experimental Therapeutics May 2001, 297 (2) 711-717;
« Previous (Pages : 1 2 3 4 5 6 ... 22) Next »
Back to top

In this issue

Advertisement